Therachon Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $810M
Latest Deal Amount

Therachon General Information

Description

Developer of novel therapeutics intended to facilitate treatment for rare genetic diseases. The company develops pipeline of therapeutics focused on rare gastrointestinal and musculoskeletal disorders and conditions, enabling medical practitioners to treat patients with short bowel syndrome and other severe conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Aeschenvorstadt 36
  • 4051 Basel
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Therachon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Jul-2019 $810M 00000 00000 Completed Generating Revenue
4. Mezzanine 09-Aug-2018 0000 00000 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 05-Jan-2017 0000 0000 Completed Startup
2. Secondary Transaction - Private Completed Startup
1. Seed Round 01-Jan-2014 Completed Startup
To view Therachon’s complete valuation and funding history, request access »

Therachon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel therapeutics intended to facilitate treatment for rare genetic diseases. The company develops pipelin
Drug Discovery
Basel, Switzerland
00000
0000 0000-00-00
000000&0 00000

0000000

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cul
0000 000000000
Cambridge, MA
000
00.00 0000-00-00
00000000000 000

0000 000

e irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excep
0000 000000000
Vancouver, Canada
0 As of 0000
000.00
000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Therachon Competitors (112)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AnTolRx Venture Capital-Backed Cambridge, MA 000 00000000000 000
0000 000000000000 Venture Capital-Backed Vancouver, Canada 0 000.00 000000 0 000.00
0000000 Formerly VC-backed Calabasas, CA 00 0000 000000&0 0000
000000000000 Venture Capital-Backed Clarksville, MD 0 00.000 000000 0
000000000000 00000 Venture Capital-Backed Jerusalem, Israel 00 000.00 00000000000 000.00
You’re viewing 5 of 112 competitors. Get the full list »

Therachon Executive Team (10)

Name Title Board Seat Contact Info
Claudia D'Augusta Ph.D Chief Financial Officer
Richard Porter Ph.D Chief Operating Officer
Matthieu Coutet Vice President of Operations & Business Development
You’re viewing 3 of 10 executive team members. Get the full list »

Therachon Board Members (10)

Name Representing Role Since
Chahra Louafi Bpifrance Board Member 000 0000
Hans Schikan Self Board Member 000 0000
Jørgen Søberg Petersen Ph.D Novo Holdings Board Member 000 0000
Patrick Machado JD Self Board Member 000 0000
Sandip Kapadia Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Therachon Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 09-Oct-2018 0000000000 Biotechnology 0000 0000
To view Therachon’s complete acquisitions history, request access »

Therachon Subsidiaries (1)

Company Name Industry Location Founded
000000000 Biotechnology Montreal, Canada 0000
To view Therachon’s complete subsidiaries history, request access »